TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Virax Biolabs Group Limited Announces $5 Million Private Placement

Benzinga Logo Benzinga By Prnewswire
Virax Biolabs Group Limited Announces $5 Million Private Placement

Virax Biolabs Group Limited has entered into agreements for a private placement of 12,500,000 ordinary shares and preferred investment options at $0.40 per share, expecting to raise $5 million for working capital and corporate purposes.

Insights
FITBP   positive

Will own approximately 73% of combined company after merger with Comerica


VRAX   positive

The company is raising capital through a private placement, indicating growth potential and investor interest in their innovative biotechnology research focused on immune response and viral disease diagnostics